BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32392378)

  • 21. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
    Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
    Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue and serum MUC1 mucin detection in breast cancer patients.
    Croce MV; Isla-Larrain MT; Demichelis SO; Gori JR; Price MR; Segal-Eiras A
    Breast Cancer Res Treat; 2003 Oct; 81(3):195-207. PubMed ID: 14620915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1).
    von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; van Kamp GJ; Kok A; van Uffelen K; Snijdewint FG; Paul MA; Meijer S; Hilgers J
    Tumour Biol; 1998; 19(3):186-95. PubMed ID: 9591045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer.
    Hamanaka Y; Suehiro Y; Fukui M; Shikichi K; Imai K; Hinoda Y
    Int J Cancer; 2003 Jan; 103(1):97-100. PubMed ID: 12455059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.
    Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
    Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
    [No Abstract]   [Full Text] [Related]  

  • 26. Circulating Antibodies to Linear Peptide Antigens Derived from ANXA1 and FOXP3 in Lung Cancer.
    Wang W; Zhong W; Chen C; Meng Q; Wei J
    Anticancer Res; 2017 Jun; 37(6):3151-3155. PubMed ID: 28551657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls.
    Snijdewint FG; von Mensdorff-Pouilly S; Karuntu-Wanamarta AH; Verstraeten AA; van Zanten-Przybysz I; Hummel P; Nijman HW; Kenemans P; Hilgers J
    Cancer Immunol Immunother; 1999 Apr; 48(1):47-55. PubMed ID: 10235488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The variation of CD4+CD25+ regulatory T cells in the periphery blood and tumor microenvironment of non-small cell lung cancer patients and the downregulation effects induced by CpG ODN.
    Wang YY; He XY; Cai YY; Wang ZJ; Lu SH
    Target Oncol; 2011 Sep; 6(3):147-54. PubMed ID: 21611754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.
    von Mensdorff-Pouilly S; Verstraeten AA; Kenemans P; Snijdewint FG; Kok A; Van Kamp GJ; Paul MA; Van Diest PJ; Meijer S; Hilgers J
    J Clin Oncol; 2000 Feb; 18(3):574-83. PubMed ID: 10653872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and application of a double- antibody sandwich ELISA kit for the detection of serum MUC1 in lung cancer patients.
    Wang J; Zhang S; Ni W; Zhai X; Xie F; Yuan H; Gao S; Tai G
    Cancer Biomark; 2016; 17(4):369-376. PubMed ID: 27636855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
    Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
    Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further analysis of natural antibodies against ischemic stroke.
    Qi J; Jiang Q; Wang P; Wang Z; Zhang X
    Front Neurol; 2023; 14():1130748. PubMed ID: 36741286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of EpCAM/MUC1 mRNA-positive cells in non-small cell lung cancer patients.
    Zhu WF; Li J; Yu LC; Wu Y; Tang XP; Hu YM; Chen YC
    Tumour Biol; 2014 Feb; 35(2):1211-9. PubMed ID: 24061641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.
    Lam S; Boyle P; Healey GF; Maddison P; Peek L; Murray A; Chapman CJ; Allen J; Wood WC; Sewell HF; Robertson JF
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1126-34. PubMed ID: 21733826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.
    Guergova-Kuras M; Kurucz I; Hempel W; Tardieu N; Kádas J; Malderez-Bloes C; Jullien A; Kieffer Y; Hincapie M; Guttman A; Csánky E; Dezso B; Karger BL; Takács L
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.010298. PubMed ID: 21947365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor.
    Oji Y; Kitamura Y; Kamino E; Kitano A; Sawabata N; Inoue M; Mori M; Nakatsuka S; Sakaguchi N; Miyazaki K; Nakamura M; Fukuda I; Nakamura J; Tatsumi N; Takakuwa T; Nishida S; Shirakata T; Hosen N; Tsuboi A; Nezu R; Maeda H; Oka Y; Kawase I; Aozasa K; Okumura M; Miyoshi S; Sugiyama H
    Int J Cancer; 2009 Jul; 125(2):381-7. PubMed ID: 19384943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profiling of Vascular Endothelial Growth Factor Receptor Heterogeneity Identifies Protein Expression-defined Subclasses of Human Non-small Cell Lung Carcinoma.
    Holzer TR; Fulford AD; Reising LO; Nedderman DM; Zhang X; Benjamin LE; Schade AE; Nasir A
    Anticancer Res; 2016 Jul; 36(7):3277-88. PubMed ID: 27354584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer.
    Burford B; Gentry-Maharaj A; Graham R; Allen D; Pedersen JW; Nudelman AS; Blixt O; Fourkala EO; Bueti D; Dawnay A; Ford J; Desai R; David L; Trinder P; Acres B; Schwientek T; Gammerman A; Reis CA; Silva L; Osório H; Hallett R; Wandall HH; Mandel U; Hollingsworth MA; Jacobs I; Fentiman I; Clausen H; Taylor-Papadimitriou J; Menon U; Burchell JM
    Br J Cancer; 2013 May; 108(10):2045-55. PubMed ID: 23652307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TA-MUC1 epitope in non-small cell lung cancer.
    Kuemmel A; Single K; Bittinger F; Faldum A; Schmidt LH; Sebastian M; Micke P; Taube C; Buhl R; Wiewrodt R
    Lung Cancer; 2009 Jan; 63(1):98-105. PubMed ID: 18539357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.